1. The effect of therapeutic plasma exchange therapy on veno-venous ECMO weaning success in severe COVID-19 ARDS patients.
- Author
-
Aslan M, Yılmaz R, Doğan M, and Çukurova Z
- Subjects
- Humans, Adult, Middle Aged, Plasma Exchange adverse effects, Retrospective Studies, Ventilator Weaning, COVID-19 therapy, Extracorporeal Membrane Oxygenation, Respiratory Distress Syndrome therapy, Respiratory Distress Syndrome etiology
- Abstract
Introduction: Primarily, this study aimed to investigate the effect of TPE (therapeutic plasma exchange) treatment on successful ECMO weaning in severe COVID-19 ARDS patients treated with V-V ECMO., Methods: The study was applied retrospectively on patients over the age of 18 who were hospitalized in the ICU between January 1, 2020 and March 1, 2022., Results: The study was performed on 33 patients, 36.3% (n: 12) of whom received TPE treatment. The rate of successful ECMO weaning was statistically higher in the TPE treatment group (without TPE: 14.3% [n: 3], with TPE: 50% [n: 6], p = 0.044). The 1-month mortality was also statistically lower in the TPE treatment group (p = 0.044). In the logistic analysis, It was found that the risk of unsuccessful ECMO weaning increased 6 times in those who did not receive TPE treatment (OR; 6.0, 95% CI; 1.134-31.735, p = 0.035)., Conclusion: TPE treatment may increase the success rate of V-V ECMO weaning in severe COVID-19 ARDS patients treated with V-V ECMO., (© 2023 International Society for Apheresis and Japanese Society for Apheresis.)
- Published
- 2023
- Full Text
- View/download PDF